58. Hypertrophic cardiomyopathy Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 126 / Drugs : 135 - (DrugBank : 42) / Drug target genes : 46 - Drug target pathways : 162
Hypertrophic cardiomyopathy and other diseases between which drug repositioning might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Drug repositionability
ID | Diseases (Sorted by drug repositionability) |
---|---|
58 | Hypertrophic cardiomyopathy |
13 | Multiple sclerosis/Neuromyelitis optica |
46 | Malignant rheumatoid arthritis |
6 | Parkinson disease |
51 | Scleroderma |
86 | Pulmonary arterial hypertension |
96 | Crohn disease |
97 | Ulcerative colitis |
113 | Muscular dystrophy |
222 | Primary nephrotic syndrome |
2 | Amyotrophic lateral sclerosis |
226 | Interstitial cystitis with Hunners ulcer |
85 | Idiopathic interstitial pneumonia |
28 | Systemic amyloidosis |
38 | Stevens-Johnson syndrome |
107 | Juvenile idiopathic arthritis |
34 | Neurofibromatosis |
50 | Dermatomyositis |
164 | Oculocutaneous albinism |
70 | Spinal stenosis |
84 | Sarcoidosis |
65 | Primary immunodeficiency |
299 | Cystic fibrosis |
151 | Rasmussen encephalitis |
298 | Hereditary pancreatitis |
67 | Polycystic kidney disease |
127 | Frontotemporal lobar degeneration |
168 | Ehlers-Danlos syndrome |
228 | Bronchiolitis obliterans |
167 | Marfan syndrome |
90 | Retinitis pigmentosa |
302 | Leber hereditary optic neuropathy |
256 | Muscle glycogenosis |
11 | Myasthenia gravis |
36 | Epidermolysis bullosa |
57 | Idiopathic dilated cardiomyopathy |
53 | Sjogren syndrome |
269 | Pyogenic arthritis |
224 | Purpura nephritis |
227 | Osler disease |
193 | Prader-Willi syndrome |
39 | Toxic epidermal necrolysis |
66 | IgA nephropathy |
158 | Tuberous sclerosis |
26 | HTLV-1-associated myelopathy |
272 | Fibrodysplasia ossificans progressiva |
55 | Relapsing polychondritis |
160 | Congenital ichthyosis |
286 | Hereditary sideroblastic anemia |
5 | Progressive supranuclear palsy |
156 | Rett syndrome |
140 | Dorabe syndrome |
144 | Lennox-Gastaut syndrome |
210 | Single Ventricle |
41 | Giant cell arteritis |
56 | Behcet disease |
218 | Alport syndrome |
49 | Systemic lupus erythematosus |
1 | Spinal and bulbar muscular atrophy |
10 | Charcot-Marie-Tooth disease |
63 | Idiopathic thrombocytopenic purpura |
45 | Eosinophilic granulomatosis with Polyangiitis |
215 | Tetralogy of Fallot |
225 | Congenital nephrogenic diabetes insipidus |
95 | Autoimmune hepatitis |
234 | Peroxisomal disease (except Adrenoleukodystrophy) |
81 | Congenital adrenal hyperplasia |
162 | Pemphigoid |
231 | Alpha-1-antitrypsin deficiency |
93 | Primary biliary cholangitis |
17 | Multiple system atrophy |
284 | Diamond-Blackfan anemia |
20 | Adrenoleukodystrophy |
274 | Osteogenesis Imperfecta |
280 | Huge arteriovenous malformation with cervicofacial or limb lesion |
19 | Lysosomal storage disease |
40 | Takayasu arteritis |
337 | Homocystinuria |
8 | Huntington disease |
169 | Menkes disease |
170 | Occipital horn syndrome |
42 | Polyarteritis nodosa |
64 | Thrombotic thrombocytopenic purpura |
326 | Osteopetrosis |
22 | Moyamoya disease |
149 | Hemiconvulsion hemiplegia epilepsy syndrome |
285 | Fanconi anemia |
114 | Non-dystrophic myotonia syndrome |
283 | Acquired pure red cell aplasia |
62 | Paroxysmal nocturnal hemoglobinuria |
60 | Aplastic anemia |
88 | Chronic thromboembolic pulmonary hypertension |
61 | Autoimmune hemolytic anemia |
102 | Rubinstein-Taybi syndrome |
89 | Lymphangioleiomyomatosis |
206 | Fragile X syndrome |
331 | Idiopathic multicentric castleman disease |
118 | Myelomeningocele |
288 | Autoimmune acquired coagulation factor deficiency |
271 | Ankylosing spondylitis |
106 | Cryopyrin-associated periodic syndrome |
251 | Urea cycle disorder |
108 | TNF receptor-associated periodic syndrome |
267 | Hyper-IgD syndrome |